Patents by Inventor Michael M. Phelipa

Michael M. Phelipa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9227029
    Abstract: In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: January 5, 2016
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Michael M. Phelipa, Robert E. Stephens
  • Patent number: 9028406
    Abstract: A system and method diagnoses esophageal reflux in a patient. A catheter includes a first pressure sensor configured to measure intra-abdominal pressure when the catheter is inserted into the stomach of a patient. A second pressure sensor is located proximal to the distal tip and configured to measure intra-thoracic pressure. A pH indicator is carried by the catheter body and configured to indicate that reflux has occurred in response to an involuntary reflex cough test. A processing device is configured to receive data regarding the first and second pressure sensors and regarding the pH indicator and process that data and assess if reflux is present during the involuntary epoch.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: May 12, 2015
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Michael M. Phelipa, Mary W. Briganti, Robert E. Stephens
  • Patent number: 9011328
    Abstract: A nasogastric/orogastric (Ng/Og) airway protection device includes an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. A main lumen extends the length of the device and is configured for at least one of gastric decompression, enteral feeding and enteral medication administration. A sump port is at the distal end. A sump lumen is formed the length of the device body and configured for venting gas and preventing adherence of the device against the gastric wall. An inflatable esophageal cuff is carried by the device body mid-esophagus and an inflation lumen is formed within the device body and connects the inflatable esophageal cuff through which the esophageal cuff is inflated and deflated. Upon inflation of the esophageal cuff, emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus to protect a patient's airway.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: April 21, 2015
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Michael M. Phelipa, Mary W. Briganti, Robert E. Stephens
  • Patent number: 8845534
    Abstract: A system and method evaluates a patient for stress urinary incontinence. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguous and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. And elecromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles and its duration determined. Any urine leakage time that occurs during the involuntary reflex cough event is identified and correlated within a processor together with the urine leakage time and EMG and duration of cough event to determine stress urinary incontinence.
    Type: Grant
    Filed: October 23, 2013
    Date of Patent: September 30, 2014
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Robert E. Stephens, Michael M. Phelipa, Mary W. Briganti
  • Patent number: 8845533
    Abstract: A system permits diagnosis of a patient for a physiological abnormality while protecting their airway. An esophageal airway protection device comprises an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. The device includes a main lumen extending the length of the device and an inflatable esophageal cuff carried by the device body mid-esophagus. Emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus when it is inflated to protect a patient's airway during an involuntary cough event. At least one electromyogram (EMG) pad is configured to obtain an EMG from an involuntary cough activated paraspinal muscles. A processing device is configured to receive the EMG and process the EMG to determine a physiological abnormality.
    Type: Grant
    Filed: October 22, 2013
    Date of Patent: September 30, 2014
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Robert E. Stephens, Michael M. Phelipa, Mary W. Briganti
  • Patent number: 8840550
    Abstract: A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
    Type: Grant
    Filed: October 22, 2013
    Date of Patent: September 23, 2014
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Robert E. Stephens, Michael M. Phelipa, Mary W. Briganti
  • Publication number: 20140088375
    Abstract: A system permits diagnosis of a patient for a physiological abnormality while protecting their airway. An esophageal airway protection device comprises an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. The device includes a main lumen extending the length of the device and an inflatable esophageal cuff carried by the device body mid-esophagus. Emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus when it is inflated to protect a patient's airway during an involuntary cough event. At least one electromyogram (EMG) pad is configured to obtain an EMG from an involuntary cough activated paraspinal muscles. A processing device is configured to receive the EMG and process the EMG to determine a physiological abnormality.
    Type: Application
    Filed: October 22, 2013
    Publication date: March 27, 2014
    Applicant: PNEUMOFLEX SYSTEMS, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Robert E. Stephens, Michael M. Phelipa, Mary W. Briganti
  • Publication number: 20140088376
    Abstract: A system and method evaluates a patient for stress urinary incontinence. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguous and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. And elecromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles and its duration determined. Any urine leakage time that occurs during the involuntary reflex cough event is identified and correlated within a processor together with the urine leakage time and EMG and duration of cough event to determine stress urinary incontinence.
    Type: Application
    Filed: October 23, 2013
    Publication date: March 27, 2014
    Applicant: PNEUMOFLEX SYSTEMS, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Robert E. Stephens, Michael M. Phelipa, Mary W. Briganti
  • Publication number: 20140046145
    Abstract: A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
    Type: Application
    Filed: October 22, 2013
    Publication date: February 13, 2014
    Applicant: PNEUMOFLEX SYSTEMS, LLC
    Inventors: W. Robert Addington, STUART P. MILLER, ROBERT E. STEPHENS, MICHAEL M. PHELIPA, MARY W. BRIGANTI
  • Publication number: 20140034051
    Abstract: In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.
    Type: Application
    Filed: October 2, 2013
    Publication date: February 6, 2014
    Applicant: PNEUMOFLEX SYSTEMS, LLC
    Inventors: W. Robert ADDINGTON, Stuart P. Miller, Michael M. Phelipa, Robert E. Stephens
  • Patent number: 8602987
    Abstract: A system and method evaluates a patient for stress urinary incontinence. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguous and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. And elecromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles and its duration determined. Any urine leakage time that occurs during the involuntary reflex cough event is identified and correlated within a processor together with the urine leakage time and EMG and duration of cough event to determine stress urinary incontinence.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: December 10, 2013
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Robert E. Stephens, Michael M. Phelipa, Mary W. Briganti, Stuart P. Miller
  • Patent number: 8597184
    Abstract: A system permits diagnosis of a patient for a physiological abnormality while protecting their airway. An esophageal airway protection device comprises an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. The device includes a main lumen extending the length of the device and an inflatable esophageal cuff carried by the device body mid-esophagus. Emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus when it is inflated to protect a patient's airway during an involuntary cough event. At least one electromyogram (EMG) pad is configured to obtain an EMG from an involuntary cough activated paraspinal muscles. A processing device is configured to receive the EMG and process the EMG to determine a physiological abnormality.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: December 3, 2013
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Michael M. Phelipa, Mary W. Briganti, Robert E. Stephens
  • Patent number: 8597183
    Abstract: A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: December 3, 2013
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Robert E. Stephens, Michael M. Phelipa, Mary W. Briganti, Stuart P. Miller
  • Publication number: 20130303862
    Abstract: A system and method allows diagnosis of a patient for physiological abnormality such as a neurological deficiency. An involuntary reflex cough event is induced within the patient that activates the nucleus ambiguus and medial motor cell column of the patient and stimulates involuntary cough activated paraspinal muscles in the pelvis of the patient. An electromyogram (EMG) is obtained from the involuntary cough activated paraspinal muscles while inducing involuntary reflex cough and determining its duration. The intra-abdominal pressure (IAP) is determined and the IAP is correlated with the EMG duration of the involuntary cough event within a processing device to diagnose a physiological abnormality such as a neurological deficiency within the patient.
    Type: Application
    Filed: July 16, 2013
    Publication date: November 14, 2013
    Inventors: W. Robert ADDINGTON, Stuart P. MILLER, Robert E. Stephens, Michael M. PHELIPA, Mary W. BRIGANTI
  • Patent number: 8573203
    Abstract: In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: November 5, 2013
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Michael M. Phelipa, Robert E. Stephens
  • Patent number: 8333190
    Abstract: In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.
    Type: Grant
    Filed: January 6, 2011
    Date of Patent: December 18, 2012
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Michael M. Phelipa, Robert E. Stephens
  • Publication number: 20120053482
    Abstract: In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.
    Type: Application
    Filed: November 10, 2011
    Publication date: March 1, 2012
    Applicant: PNEUMOFLEX SYSTEMS, LLC
    Inventors: W. Robert ADDINGTON, Stuart P. Miller, Michael M. Phelipa, Robert E. Stephens
  • Patent number: 8109266
    Abstract: In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: February 7, 2012
    Assignee: Pneumoflex Systems, LLC
    Inventors: W. Robert Addington, Stuart P. Miller, Michael M. Phelipa, Robert E. Stephens
  • Publication number: 20110105936
    Abstract: In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.
    Type: Application
    Filed: January 6, 2011
    Publication date: May 5, 2011
    Applicant: Pneumoflex Systems, LLC
    Inventors: W. Robert ADDINGTON, Stuart P. MILLER, Michael M. PHELIPA, Robert E. STEPHENS
  • Publication number: 20110046653
    Abstract: A nasogastric/orogastric (Ng/Og) airway protection device includes an elongate device body having a distal end for insertion into the stomach through the esophagus and a proximal end. A main lumen extends the length of the device and is configured for at least one of gastric decompression, enteral feeding and enteral medication administration. A sump port is at the distal end. A sump lumen is formed the length of the device body and configured for venting gas and preventing adherence of the device against the gastric wall. An inflatable esophageal cuff is carried by the device body mid-esophagus and an inflation lumen is formed within the device body and connects the inflatable esophageal cuff through which the esophageal cuff is inflated and deflated. Upon inflation of the esophageal cuff, emesis and/or reflux is blocked from passing out of the stomach past the esophageal cuff positioned mid-esophagus to protect a patient's airway.
    Type: Application
    Filed: September 9, 2010
    Publication date: February 24, 2011
    Applicant: PNEUMOFLEX SYSTEMS, LLC, State of Incorporation: Florida
    Inventors: W. Robert Addington, Stuart P. Miller, Michael M. Phelipa, Mary W. Briganti, Robert E. Stephens